SCHEMBL118097

SCHEMBL118097

CCC(CC)(Oc1cc(-c2oc3cc(OCc4ccccc4)ccc3c(=O)c2OCc2ccccc2)ccc1OCc1ccccc1)O[PH](=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 2/20 0.43
PPARG P37231 1/20 0.43
ABCG2 Q9UNQ0 4/20 0.42
MAOB P27338 4/20 0.42
ACHE P22303 1/20 0.42
NPC1 O15118 1/20 0.41
MAOA P21397 1/20 0.41
CASP3 P42574 1/20 0.41
RAB9A P51151 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 2/20 0.41
TP53 P04637 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
CYP19A1 P11511 2/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL117685 0.85 ACE2 (0.44) ACE2PPARGABCG2MAOBACHE
SCHEMBL4150944 0.80 MAOB (0.51) ACE2PPARGABCG2MAOBACHE
SCHEMBL4153233 0.80 ABCG2 (0.63) PPARGABCG2MAOBACHENPC1
SCHEMBL117674 0.80 MAOB (0.50) ACE2PPARGABCG2MAOBACHE
SCHEMBL3718620 0.79 ABCG2 (0.46) ACE2PPARGABCG2MAOBACHE
SCHEMBL4150940 0.79 ABCG2 (0.48) ACE2PPARGABCG2MAOBACHE
SCHEMBL1421774 0.78 ABCG2 (0.61) PPARGABCG2MAOBACHENPC1
SCHEMBL3759824 0.78 MAOB (0.46) ACE2PPARGABCG2MAOBACHE
SCHEMBL13056287 0.78 ACE2 (0.47) ACE2PPARGABCG2MAOBACHE
SCHEMBL7548319 0.78 MAOB (0.48) ACE2ABCG2MAOBACHENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424541-A2 PHOSPHORYLATED AND PHOSPHONATED PYRONE ANALOGS FOR THERAPEUTIC TREATMENT Limerick BioPharma, Inc. (US) 2012-03-07 EP disclosed